404
+1-313-307-4176
Molecular Chlamydia Trachomatis Neisseria Gonorrhoeae Diagnostic Equipment Market Report
Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market Trends, Dynamics & Market Insights
Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market, By Type (Pcr, In Situ Hybridization, Chips And Microarrays, Isothermal Nucleic Acid Amplification Technology (Inaat), Mass Spectrometry, Sequencing, Transcription Mediated Amplification), Application (Hospital, Research, Clinic), and Region - COVID-19 Impact Analysis and Forecast to 2026.
This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment market. The historic years considered for the study are 2016-2019, the base year is 2020, and the forecast period is 2021-2026.
The Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment market is projected to grow from USD xx billion in 2020 to USD xx billion by 2026 at a CAGR of around x% during the forecast period.
Wish to get a free sample? Register Here
Chlamydia trachomatis and Neisseria gonorrhoeae are known to be the most prevalent sexually transmitted pathogens having high rates of infection among female commercial sex workers in developing countries. The equipment used to diagnose chlamydia trachomatis and neisseria gonorrhoeae include PCR, in situ hybridization, chips and microarrays, isothermal nucleic acid amplification technology (inaat), and mass spectrometry among others.
Key players operating in the Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment market are-
The growth of molecular chlamydia trachomatis (CT)/neisseria gonorrhoeae (NG) diagnostic equipment market is primarily driven by increasing incidences of sexually transmitted diseases. Growing emphasis on education campaigns to create awareness and government initiatives are anticipated to drive the growth of molecular chlamydia trachomatis (CT)/neisseria gonorrhoeae (NG) diagnostic equipment at a significant rate during the review period. In addition to this, surging demand for advanced CT/NG diagnostic equipment is likely to create lucrative opportunities for the players operating in the global market in the coming years.
By application, the molecular chlamydia trachomatis (CT)/neisseria gonorrhoeae (NG) diagnostic equipment market has been bifurcated into hospital, research and clinic. Under these, the hospitals segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period.
By region, the market in North America accounted for the largest market share in 2020 and is projected to grow at a significant CAGR during the assessment period. The segment growth is primarily attributed to high demand for advanced CT/NG diagnostic equipment coupled with presence of key market players such as Cepheid (US) and Becton, Dickinson and Company (US). The market growth in Asia-Pacific region is expected to be driven by rising number of people suffering from CT/NG.
The outbreak of COVID-19 virus posed significant challenges to the growth of the healthcare industry significantly. Stringent lockdown measures and restricted movement of people affected the product demand and supply for a short period of time.
Here is the list of the group of customers that the Molecular chlamydia trachomatis (CT)/neisseria gonorrhoeae (NG) diagnostic equipment market hopes to have the greatest opportunity to convert-
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].
Cepheid (US), Becton, Dickinson and Company (US), Gen-Probe (US), QIAGEN (Germany), F. Hoffmann-La Roche AG (Switzerland), Bayer AG (Germany), Dako (Denmark), Abbott Laborato-ries (US), Danaher Corporation (US), Siemens AG (Germany), Sysmex Corporation (Japan), Grifols, S.A. (Spain) and bioMérieux SA (France) are among the key players in the molecular CT/NG diagnostic equipment market.
Increasing incidences of sexually transmitted diseases is the prime factor driving the growth of molecular CT/NG diagnostic equipment market.
The hospitals segment is expected to register the significant growth in the molecular CT/NG diagnostic equipment market in the coming years.
North America accounted for the largest share in the molecular CT/NG diagnostic equipment market in 2020.
Molecular chlamydia trachomatis (CT)/neisseria gonorrhoeae (NG) diagnostic equipment distributors, Molecular chlamydia trachomatis (CT)/neisseria gonorrhoeae (NG) diagnostic equipment suppliers, Molecular chlamydia trachomatis (CT)/neisseria gonorrhoeae (NG) diagnostic equipment manufacturers, Logistics organizations, Government bodies are the target audience in the molecular CT/NG diagnostic equipment market.
WE ACCEPT
